Form 4 Tracker
Mark Schoenberg

Chief Medical Officer · 8 filings · Latest: Sep 7, 2026

UroGen Pharma Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
URGN
Mark SchoenbergChief Medical OfficerSep 8, 2026
Sale
$42.92871$37.4K59,882
URGN
Mark SchoenbergChief Medical OfficerSep 7, 2026
Option Exercise
—1,667—60,753
URGN
Mark Schoenberg—Sep 8, 2026
Proposed Sale
$44.09871$38.4K—
URGN
Mark SchoenbergChief Medical OfficerAug 20, 2026
Sale
$47.0560,677$2.9M59,086
URGN
Schoenberg Mark—Aug 20, 2026
Proposed Sale
$47.6760,677$2.9M—
URGN
Mark SchoenbergChief Medical OfficerJul 9, 2026
Sale
$40.0010,000$400.0K119,763
URGN
Schoenberg Mark—Jul 9, 2026
Proposed Sale
$40.0010,000$400.0K—
URGN
Mark SchoenbergChief Medical OfficerJun 22, 2026
Sale
$35.0110,000$350.1K129,763
URGN
Schoenberg Mark—Jun 22, 2026
Proposed Sale
$35.0110,000$350.1K—
URGN
Mark SchoenbergChief Medical OfficerJun 8, 2026
Sale
$27.305,222$142.6K139,763
URGN
Mark SchoenbergChief Medical OfficerJun 8, 2026
Option Exercise
—10,000—144,985
URGN
Schoenberg Mark—Jun 8, 2026
Proposed Sale
$26.855,222$140.2K—
URGN
Mark SchoenbergChief Medical OfficerMay 8, 2026
Sale
$30.0010,000$300.0K134,985
URGN
Schoenberg Mark—May 8, 2026
Proposed Sale
$30.0010,000$300.0K—
URGN
Mark SchoenbergChief Medical OfficerFeb 3, 2026
Sale
$19.697,373$145.2K144,985
URGN
Mark SchoenbergChief Medical OfficerJan 31, 2026
Option Exercise
—13,333—142,359
URGN
Schoenberg Mark—Feb 2, 2026
Proposed Sale
$19.6113,333$261.5K—
URGN
Schoenberg Mark—Nov 19, 2025
Proposed Sale
$25.0010,000$250.0K—
URGN
Schoenberg Mark—Sep 8, 2025
Proposed Sale
$18.88871$16.4K—
URGN
Schoenberg Mark—Jul 28, 2025
Proposed Sale
$18.955,149$97.6K—

Page 1 of 2

Next →